Pulmocit (B): Negotiating Pharmaceutical Products with the Government Harvard Case Solution & Analysis

It is a two party negotiation between a government agency along with a pharmaceutical company to determine if a brand new medicine will be put on the reimbursement list. The pharmaceutical company has a valuable new merchandise, the government has semi-monopolistic power over whether (or not) drugs are listed. Participants of the role-play are permitted to negotiate given the inherent value-creation limitations of the setting.

Pulmocit (B) Negotiating Pharmaceutical Products with the Government Case Study Solution

PUBLICATION DATE: January 27, 2014 PRODUCT #: INS388-PDF-ENG

This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE

Pulmocit (B): Negotiating Pharmaceutical Products with the Government Case Solution Other Similar Case Solutions like

Pulmocit (B): Negotiating Pharmaceutical Products with the Government

Share This